Metraipolis › archive › dc_945f929ddfe4

Early endocrine diagnoses and subsequent survival after immune checkpoint inhibitor initiation in non-small cell lung cancer: a 180-day landmark cohort study — Europe PMC PMID:42825071

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42825071
DOI
10.3389/fonc.2026.1957383
License (as archived)
solo-consultazione
Archived
2026-10-08T07:46:29.160Z
SHA-256 of the archived text
b8342f0d6e25cd79bb6b23c784298d1657bcb03f661797028fce9203a3aa13cc
Stable URL of this page
https://metraipolis.com/documento/dc_945f929ddfe4

How to cite

Early endocrine diagnoses and subsequent survival after immune checkpoint inhibitor initiation in non-small cell lung cancer: a 180-day landmark cohort study — Europe PMC PMID:42825071 — Europe PMC (en), https://europepmc.org/article/MED/42825071 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_945f929ddfe4 (Metraipolis archive dc_945f929ddfe4, sha256 b8342f0d6e25cd79bb6b23c784298d1657bcb03f661797028fce9203a3aa13cc)
BibTeX
@misc{dc945f929ddfe4,
  title = {Early endocrine diagnoses and subsequent survival after immune checkpoint inhibitor initiation in non-small cell lung cancer: a 180-day landmark cohort study — Europe PMC PMID:42825071},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42825071},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_945f929ddfe4; sha256 b8342f0d6e25cd79bb6b23c784298d1657bcb03f661797028fce9203a3aa13cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42825071. Agents can read the archived copy with the MCP tool read_document.